Back
Expedia Group Vs. Novo Nordisk AS Industry Stock Comparison
Buy
83
EXPE
Expedia Group
Last Price:
$184.73
Seasonality Move:
-0.48%
Sell
13
NONOF
Novo Nordisk AS
Last Price:
$84.75
Seasonality Move:
6.94%
Buy
83
Expedia Group (EXPE)
is a Buy
Is Expedia Group a Buy, Sell or Hold?
-
The current Expedia Group [EXPE] share price is $184.71. The Score for EXPE is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
-
EXPE is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
13
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $84.75. The Score for NONOF is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
EXPE Stock Price Chart
What is Expedia Group's stock price today?
-
The Expedia Group share price today is $184.71Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EXPE is experiencing buying pressure, which is a positive indicator for future bullish movement.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $84.75Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.
EXPE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.82 | Buy |
| Relative Strength Index (14 RSI): | 55.58 | Buy |
| Chaikin Money Flow: | 3285448 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (180.17 - 188.17) | Buy |
| Bollinger Bands (100): | (132.82 - 177.24) | Buy |
NONOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.51 | Sell |
| Relative Strength Index (14 RSI): | 24.55 | Sell |
| Chaikin Money Flow: | 64911 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (100.57 - 111.43) | Sell |
| Bollinger Bands (100): | (107.18 - 131.16) | Sell |
EXPE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 182.68 | Buy |
| 20-day SMA: | 185.14 | Sell |
| 50-day SMA: | 173.89 | Buy |
| 200-day SMA: | 140.84 | Buy |
| 8-day EMA: | 182.57 | Buy |
| 20-day EMA: | 182.63 | Buy |
| 50-day EMA: | 173.97 | Buy |
| 200-day EMA: | 148.22 | Buy |
NONOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.03 | Sell |
| 20-day SMA: | 106.85 | Sell |
| 50-day SMA: | 109.33 | Sell |
| 200-day SMA: | 126.14 | Sell |
| 8-day EMA: | 102.09 | Sell |
| 20-day EMA: | 105.65 | Sell |
| 50-day EMA: | 110.06 | Sell |
| 200-day EMA: | 118.01 | Sell |
Expedia Group Earnings Growth & EXPE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.88 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.17 per share, and an increase next year of $2.33 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.
Expedia Group Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk AS Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||